[1]
Kucherenko, L.I. and Okolzin, D.V. 2025. The relevance of creating a new combined ophthalmic drug with anti-inflammatory and antibacterial effects. Current issues in pharmacy and medicine: science and practice. 18, 2 (Jul. 2025), 215–222. DOI:https://doi.org/10.14739/2409-2932.2025.2.325216.